IDEAS home Printed from https://ideas.repec.org/p/hhs/ihewps/2026_006.html

Tröskelvärdet – värdet av hälsa och nytta i prissättning av nya innovativa läkemedel

Author

Listed:
  • Persson, Ulf

    (IHE - The Swedish Institute for Health Economics)

Abstract

Cost-effectiveness analysis involves calculating the incremental cost per quality-adjusted life year (QALY) gained. The maximum acceptable cost per QALY is commonly referred to as the threshold value. The threshold value thus provides an indication of what is considered acceptable by the authority or organization responsible for assessing the value of the new medical technology. This report provides an overview of the threshold value, what it is, how it can be estimated, and the questions it is intended to answer. The threshold value is closely linked to the principles of value-based pricing (VBP) that we use in Sweden. The report proposes raising the TLV’s threshold values from an average of approximately 870,000 SEK to 1.3 million SEK for innovative patented medicines.

Suggested Citation

  • Persson, Ulf, 2026. "Tröskelvärdet – värdet av hälsa och nytta i prissättning av nya innovativa läkemedel," IHE Report / IHE Rapport 2026:6, IHE - The Swedish Institute for Health Economics.
    • Handle: RePEc:hhs:ihewps:2026_006
    Note: The report is written in Swedish with a summary in English
    as

    Download full text from publisher

    File URL: https://ihe.se/app/uploads/2026/06/IHE-RAPPORT-2026_6_.pdf
    File Function: Full text
    Download Restriction: no
    ---><---

    More about this item

    Keywords

    ;
    ;
    ;
    ;
    ;
    ;
    ;
    ;
    ;
    ;

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:hhs:ihewps:2026_006. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Annette Persson Dietmann (email available below). General contact details of provider: https://ihe.se/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.